Good outcome associated with blood-brain barrier disruption and lower blood pressure after endovascular therapy

医学 血压 内科学 逻辑回归 血脑屏障 心脏病学 随机对照试验 冲程(发动机) 机械工程 工程类 中枢神经系统
作者
Parth Upadhyaya,Amit Mehta,Marie Luby,Saeed Ansari,J.A. Lynch,Amie W. Hsia,Lawrence L. Latour,Yongwoo Kim
出处
期刊:Journal of stroke and cerebrovascular diseases [Elsevier BV]
卷期号:32 (1): 106870-106870 被引量:9
标识
DOI:10.1016/j.jstrokecerebrovasdis.2022.106870
摘要

Abstract

Objectives

To evaluate the association between post-endovascular thrombectomy (EVT) blood-brain barrier (BBB) disruption on MRI or CT and average systolic blood pressure (SBP) with favorable 90-day functional outcome. Observational studies have found elevated SBP associated with worse outcomes post-EVT, while recent randomized trials found no difference in targeted BP reduction. There may be a subgroup of patients who benefit from targeted BP reduction post-EVT.

Methods

This is a single-center study of 1) anterior large vessel occlusion stroke patients treated with EVT from 2015 to 2021, 2) achieved mTICI grade 2b or 3. Hyperintense acute reperfusion marker (HARM), hemorrhagic transformation (HT), and midline shift at 3 h post-EVT and 24 h imaging were assessed independently by multiple raters. Binary logistic regression models were used to determine the association of post-EVT SBP with outcomes. BBB disruption was defined as HT or HARM on 3h post-EVT imaging.

Results

Of 103 patients, those with SBP 100-129 versus SBP 130-160 found no significant difference in favorable 90-day outcome (64% vs. 46%, OR 2.11, 95% CI 0.78-5.76, p=0.143). However, among 71 patients with BBB disruption, a significant difference in favorable outcome of 64% in SBP 100-129 vs. 39% in SBP 130-160 group (OR 5.93, 95% CI 1.50-23.45, p=0.011) was found. There was no difference in symptomatic ICH, 90-day mortality, midline shift (≥5 mm), and hemicraniectomy, between BP or BBB groups.

Conclusions

BBB disruption on 3h post-EVT imaging and lower SBP was associated with favorable outcome. This imaging finding may guide targeted BP therapy and suggests need for a randomized control trial.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
evvj发布了新的文献求助10
1秒前
坚果完成签到,获得积分10
1秒前
1秒前
2秒前
3秒前
今年我必胖20斤完成签到,获得积分10
4秒前
害羞静柏完成签到,获得积分20
4秒前
5秒前
DavidYey发布了新的文献求助10
5秒前
5秒前
小安完成签到 ,获得积分10
5秒前
5秒前
惠飞薇完成签到 ,获得积分10
6秒前
执着时光发布了新的文献求助10
6秒前
NexusExplorer应助科研通管家采纳,获得10
6秒前
汉堡包应助科研通管家采纳,获得10
6秒前
Owen应助科研通管家采纳,获得10
6秒前
敏感凡双应助科研通管家采纳,获得10
6秒前
CipherSage应助科研通管家采纳,获得10
6秒前
猫爱吃鱼发布了新的文献求助10
6秒前
李爱国应助科研通管家采纳,获得10
6秒前
上官若男应助科研通管家采纳,获得10
7秒前
敏感凡双应助科研通管家采纳,获得10
7秒前
不倦应助科研通管家采纳,获得10
7秒前
7秒前
隐形曼青应助科研通管家采纳,获得10
7秒前
7秒前
彭于彦祖应助科研通管家采纳,获得20
7秒前
敏感凡双应助科研通管家采纳,获得10
7秒前
不想干活应助科研通管家采纳,获得10
7秒前
7秒前
桐桐应助科研通管家采纳,获得10
7秒前
不倦应助科研通管家采纳,获得10
7秒前
英俊的铭应助科研通管家采纳,获得10
7秒前
走走走发布了新的文献求助10
7秒前
不想干活应助科研通管家采纳,获得10
7秒前
東染完成签到,获得积分10
8秒前
8秒前
科研通AI5应助Juice采纳,获得10
8秒前
不想干活应助科研通管家采纳,获得10
8秒前
高分求助中
(应助此贴封号)【重要!!请各位详细阅读】【科研通的精品贴汇总】 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
F-35B V2.0 How to build Kitty Hawk's F-35B Version 2.0 Model 2500
줄기세포 생물학 1000
The Netter Collection of Medical Illustrations: Digestive System, Volume 9, Part III - Liver, Biliary Tract, and Pancreas (3rd Edition) 600
INQUIRY-BASED PEDAGOGY TO SUPPORT STEM LEARNING AND 21ST CENTURY SKILLS: PREPARING NEW TEACHERS TO IMPLEMENT PROJECT AND PROBLEM-BASED LEARNING 500
2025-2031全球及中国蛋黄lgY抗体行业研究及十五五规划分析报告(2025-2031 Global and China Chicken lgY Antibody Industry Research and 15th Five Year Plan Analysis Report) 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4492378
求助须知:如何正确求助?哪些是违规求助? 3945749
关于积分的说明 12235567
捐赠科研通 3603040
什么是DOI,文献DOI怎么找? 1981540
邀请新用户注册赠送积分活动 1018371
科研通“疑难数据库(出版商)”最低求助积分说明 911059